Abstract: The present invention relates to a composition for a gel polymer electrolyte comprising a liquid electrolyte solvent, a lithium salt, a polymerization initiator, and a mixed compound of a first compound and a second compound, and a lithium secondary battery comprising a positive electrode, a negative electrode, a separator, and a gel polymer electrolyte, wherein the gel polymer electrolyte is formed by polymerizing the composition for a gel polymer electrolyte. By comprising a mixed compound of a first compound and a second compound in which the first compound is an amine-based compound comprising polyethylene glycol as a functional group and the second compound is an epoxy-based compound, a composition for a gel polymer electrolyte of the present invention exhibits, when used in a lithium secondary battery, enhanced battery lifespan, excellent high temperature storability, and enhanced battery capacity property by readily inducing a hopping phenomenon.

Abstract: Described are methods, devices, and systems for a novel, easy to use treatment for spasticity that does not involve medication. Methods and devices herein use low-frequency repetitive magnetic fields to enhance communication in the spinal nerve, thereby allowing improved relaxation, control, and coordination in a muscle.

Abstract: Described are novel methods for the diagnosis of specific mental disorders using neurometrics. EEG parameters are compared to thresholds to determine if a person is suffering from autism spectrum disorder, Alzheimer's disease, anxiety, depression, or schizophrenia.

Abstract: Described are novel systems for the diagnosis of specific mental disorders using neurometrics. EEG parameters are compared to thresholds to determine if a person is suffering from autism spectrum disorder, Alzheimer's disease, anxiety, depression, or schizophrenia.

Abstract: The invention provides compositions, each comprising an ethylene/alpha-olefin interpolymer, which has a reduced level of a low density, low molecular weight oligomeric fraction, as indicated by an HCC value, as described herein, and reduced levels of inorganic content or lower Tm. The invention also provides processes for forming such interpolymers.

Abstract: A high voltage level shifter includes a first high-voltage P-channel metal oxide semiconductor (HVPMOS) transistor, a second HVPMOS transistor, a discharge transistor having a first native high-voltage N-channel metal oxide semiconductor (HVNMOS) transistor and a first low-voltage N-channel metal oxide semiconductor (LVNMOS) transistor connected in series, and an avalanche transistor having a second HVNMOS transistor and a second LVNMOS transistor connected in series.

Abstract: Described are methods, devices, and systems for a novel, easy-to-use treatment for pain that does not involve medication. Methods and devices herein use repetitive magnetic fields that desensitize the spinal nerve, thereby affecting transmission of pain signals from the treatment location to the brain.

Abstract: The present disclosure provides a composition. In an embodiment an adhesive composition is provided and includes A) a propylene based plastomer or elastomer (PBPE) comprising up to 10 wt % units derived from ethylene and having (i) a Koenig B-value less than 1.0; (ii) a total unsaturation per mole of propylene from 0.01% to 0.03%; (iii) a density from 0.870 g/cc to 0.890 g/cc; (iv) a melt viscosity at 177° C. from 800 mPa·s to 11,000 mPa·s; and (v) a weight average molecular weight from 20,000 to 50,000 g/mol; B) a tackifies; and C) a wax.

Abstract: A hot melt adhesive composition includes (A) 10-95 wt % of a random or homogeneous propylene-based interpolymer having: (i) a comonomer content of at least one of C2 and C4-10 a-olefin of 7 wt % to 49 wt % based on the total weight of the propylene-based interpolymer, (ii) an MWD of 4 or less, (iii) a density of 0.

Abstract: A hot melt adhesive (HMA) composition includes (A) from 1-60 wt % of a block composite compatibilizer comprising (i) a hard polymer that includes propylene, (ii) a soft polymer that includes ethylene, and (iii) a block copolymer having a soft block and a hard block, the hard block of the block copolymer having the same composition as the hard polymer of the block composite compatibilizer and the soft block of the block copolymer having the same composition as the soft polymer of the block composite compatibilizer; (B) from 1-70 wt % of a tackifier; (C) from 1-40 wt % of at least one selected from the group of a wax and an oil; and (D) Optionally, from greater than zero to 97 wt % of a polymer component that includes an ethylene-based polymer and/or a propylene-based polymer.

Abstract: A composition includes (A) 30-95 wt % of a random or homogeneous propylene-based interpolymer having: (i) a comonomer content of at least one of C2 and C4-10 ?-olefins of 7 wt % to 49 wt % based on the total weight of the propylene-based interpolymer, (ii) a density of 0.90 g/cc or less, and (iii) an MFR of 1 g/10 min or greater (230° C./2.16 kg); and (B) 5-70 wt % of a block composite nucleator comprising: (1) a first polymer that includes polypropylene; (2) a second polymer that includes an alpha-olefin based polymer, the alpha-olefin being selected from at least one of a C2 and C4-10 ?-olefins, and (3) a block copolymer having a first segment and a second segment, the first segment of the block copolymer having the same composition as the first polymer in the block composite nucleator and the second segment of the block copolymer having the same composition as the second polymer of the block composite nucleator.

Abstract: The present disclosure provides an adhesive composition. The adhesive composition includes: A) a propylene based plastomer or elastomer (PBPE) comprising up to 15 wt % units derived from ethylene and having (i) a Koenig B-value less than 1.0; (ii) a total unsaturation per mole of propylene from 0.010% to 0.030%; (iii) a density from 0.860 g/cc to 0.890 g/cc; (iv) a melt viscosity at 177° C. from 1,000 mPa·s to 15,000 mPa·s; and (v) a weight average molecular weight from 20,000 to 50,000 g/mole.

Abstract: Provided are a gel polymer electrolyte including a polymer network, and an electrolyte solution impregnated in the polymer network, wherein the polymer network is formed by combining a first oligomer, which includes unit A derived from a monomer including at least one copolymerizable acrylate or acrylic acid, unit C including urethane, and unit E including alkylene group substituted with one or more fluorine, in a three-dimensional structure, and a lithium secondary battery including the gel polymer electrolyte.

Abstract: Described are methods, devices, and systems for a novel, inexpensive, easy to use therapy for treatment of coma, post-traumatic stress disorder, Parkinson's disease, cognitive performance, and/or amblyopia. Described are methods and devices to treat coma, post-traumatic stress disorder, Parkinson's disease, cognitive performance, and/or amblyopia that involves no medication. Methods and devices described herein use alternating magnetic fields to gently “tune” the brain and affect symptoms of coma, post-traumatic stress disorder, Parkinson's disease, cognitive performance, and/or amblyopia.

Abstract: A public land mobile network (PLMN) selection procedure may be generated that, when implemented, disables at least one resource of a particular mobile device to prevent a scan of particular ones of PLMNS that exhibit supported access technologies, and/or supported frequency bands of supported access technologies, incompatible with a preferred operation of the particular mobile terminal.

Abstract: A method for searching network at startup, a Communication Processor (CP) and a terminal equipment are provided. The method includes: after the CP is powered on and initialized, determining characteristic information of networks supported by the CP; searching for available networks according to the network characteristic information, and obtaining available network information; and obtaining a network searching instruction transmitted from an Application Processor (AP), and determining a network searching result according to the available network information. The method reduces the time for searching network at startup.

Abstract: The invention provides compositions, each comprising an ethylene/alpha-olefin interpolymer, which has a reduced level of a low density, low molecular weight oligomeric fraction, as indicated by an HCC value, as described herein, and reduced levels of inorganic content or lower Tm. The invention also provides processes for forming such interpolymers.

Abstract: A computer system includes an addressing assembly, connected respectively to high bits of a memory address line of a processor and high bits of a word address line of a storage, and used to convert, in a preset continuous or discrete range on the storage, high bits of a memory address formed by the processor into high bits of a corresponding word address of the storage and output the high bits to the storage. Low bits of the memory address line of the processor are connected to low bits of the word address line of the storage. The preset range is smaller than or equal to an addressing range of the memory address line of the processor. The processor changes storage units of the storage covered by the preset range by changing the preset range. Thus it reduces cost, improves operation efficiency, shortens operation time, and has wide applicability.

Abstract: Described herein, in certain embodiments, are devices and methods for modulating the electrical activity of a brain in a targeted manner using a weak magnetic field, generally field with a strength of less than about 100 Gauss. The magnetic field is varied over time in a periodic manner, generally with a frequency tuned to specifically affect one of the intrinsic frequencies of the brain, optionally the alpha frequency. The “Low Field Magnetic Stimulation” devices and methods described herein modulate the electrical activity of a brain without requiring medication. Methods and devices described herein gently “tune” the brain and affect mood, focus, and cognition of human subjects.

Abstract: The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens.